共查询到20条相似文献，搜索用时 62 毫秒
1.
郭昭林 《畜牧兽医科技信息》2012,(2):6-9
《行政许可法》规定,法律可以对法定事项设定行政许可。修订后的《动物防疫法》在《行政许可法》第十二条规定的可以设定行政许可的事项内,设定或进一步明确了相关的行政许可。农业部相继出台的《动物检疫管理办法》(农业部令2010第6号)、《动物防疫条件审查办法》(农业部令2010第7号)等配套规章和文件,对实施这些行政许可从实施机关、范围、条件、程序和期限等方面作出了更加具体的规定。现将目前掌握的资料进行整理归纳,有些内容属个人 相似文献
2.
《行政许可法》是调整行政许可的设定和实施的法律，不属于行政许可的政府行为不适用《行政许可法》的规定。在理解行政许可的概念时，应当把握以下4个特征： 相似文献
3.
4.
5.
《中华人民共和国行政许可法》(以下简称《行政许可法》)于2004年7月正式实施。动物防疫监督机构不是行政机关，有无权力实施行政许可?有权实施哪些行政许可?法律依据是什么?做好这些行政许可要注意解决哪些问题?是动物防疫主管及实施人员急需掌握的问题，下面将本人对上述问题的学习心得和大家一起分享。 相似文献
6.
《中华人民共和国行政许可法》(以下简称《行政许可法》)的实施对规范行政许可的设定和实施，保护公民、法人和其它组织的合法权益，维护公共利益和社会秩序，保障和监督行政机关有效实施行政管理，具有极其重要的作用。行政机关必须依照这部法律的规定实沲其行政许可。 相似文献
7.
8.
《行政许可法》第23条规定：“法律、法规授权的具有管理公共事务职能的组织，在法定的授权范围内，以自己的名义实施行政许可”。《动物防疫法》第45条规定：“动物饲养场、屠宰场、肉类联合加工厂和其他定点屠宰场等单位，从事动物饲养、经营和动物产品生产、经营活动，应当符合国务院畜牧行政管理部门规定的动物防疫条件，并接受动物防疫监督机构的监督检查”。 相似文献
9.
根据《行政许可法》第二条的规定,行政许可是指行政机关根据公民、法人或其他组织的申请,经依法审查,准于其从事特定活动的行为。其功能主要是控制危险,配置资源,证明或提供某种信息与信誉;《中华人民共和国动物防疫法》(以下简称《动物防疫法》)中的许多具体行政行为均符合以上特征,因此,这些具体行政行为可称为动物防疫行政许可(也可称为动物卫生行政许可等),它涉及到家畜家禽、野生动物、水生动物、蚕等的每次移动和屠宰加工等。 相似文献
10.
11.
１销售员管理的目标销售员管理就是在不断培养提高销售员素质的过程中，激励引导销售员积极认真地为饲料企业收集有利于饲料企业长远发展的信息，注意刺激顾客需求，顺利推销饲料企业产品，不断扩大饲料企业市场份额的过程。具体体现在以下几个方面：１．１优化销售员队伍结构，不断提高销售员素质，以较少的投入获得较大的推销业绩众所周知，刚入门的销售员与优秀销售员的水平相差甚远。这就给销售员管理者提供了一个较大的工作显效空间，也同时面临着几种销售员队伍结构组合的选择：第一种是低低组合，即只配备清一色的低素质销售员，其结… 相似文献
12.
<正>随着家禽养殖业的发展,国内的肉鸡养殖模式发生很大变化,正在逐步由饲养规模比较小的散养户向规模化和集约化的饲养模式发展,这样可以使养殖场生产管理更加标准化和统一化,有利于肉鸡群的饲养管理和卫生防疫。但是随着生产规模的不断扩大,肉鸡群免疫接种工作的难度也日益加大。 相似文献
13.
R.K. Peters T. Schubert R. Clemmons T. Vickroy 《Journal of veterinary internal medicine / American College of Veterinary Internal Medicine》2014,28(2):504-509
Background
Levetiracetam is used to manage status epilepticus (SE) and cluster seizures (CS) in humans. The drug might be absorbed after rectal administration and could offer a practical adjunct to rectal administration of diazepam in managing SE and CS.Hypothesis
Levetiracetam is rapidly absorbed after rectal administration in dogs and maintains target serum concentrations for at least 9 hours.Animals
Six healthy privately owned dogs between 2 and 6 years of age and weighing 10–20 kg.Methods
Levetiracetam (40 mg/kg) was administered rectally and blood samples were obtained immediately before (time zero) and at 10, 20, 40, 60, 90, 180, 360, and 540 minutes after drug administration. Dogs were observed for signs of adverse effects over a 24‐hour period after drug administration.Results
C LEV at 10 minutes was 15.3 ± 5.5 μg/mL (mean, SD) with concentrations in the target range (5–40 μg/mL) for all dogs throughout the sampling period. C max (36.0 ± 10.7 μg/mL) and T max (103 ± 31 minutes) values were calculated and 2 disparate groups were appreciated. Dogs with feces in the rectum at the time of drug administration had lower mean C max values (26.7 ± 3.4 μg/mL) compared with those without (45.2 ± 4.4 μg/mL). Mild sedation was observed between 60 and 90 minutes without other adverse effects noted.Conclusions and Clinical Importance
This study supports the use of rectally administered levetiracetam in future studies of clinical effectiveness in the management of epileptic dogs. 相似文献14.
John Maas DVM MS John R. Peauroi DVM MPVM Terry Tonjes BS Julianne Karlonas BS Francis D. Galey DVM PhD Bin Han BVM 《Journal of veterinary internal medicine / American College of Veterinary Internal Medicine》1993,7(6):342-348
Nine recently weaned Hereford heifers were randomly assigned to a control group (n = 3) or a treatment group (n = 6). The animals were selenium (Se) deficient (mean ± SD blood Se concentration = 0.024 ± 0.012 μg/mL). They were maintained on a selenium-deficient diet, and on day 0 of the study the treatment group was given 0.05 mg Se/kg body weight intramuscularly, while the control group received a placebo. The Se concentration of blood, serum, and urine as well as the glutathione peroxidase (GSH-Px) activity of blood and serum was measured over an 84-day period. Peak blood Se and serum Se concentrations (mean ± SD) in the treatment group occurred at 5 hours postinjection and were 0.131 ± 0.028 μg/mL and 0.154 ± 0.027 μg/mL, respectively. The mean blood Se concentration of the treatment group was greater (P < .05) than that of the control group for the first 28 days after injection. The mean serum Se concentration of the treatment group was greater (P < .05) than that of the control group for all times after injection, except for day 56. The mean (±SD) blood GSH-Px activity of the treatment group (12.0 ± 2.3 mU/min/mg hemoglobin) was increased (P < .05) over the control group (2.0 ± 1.4 mU/min/ mg hemoglobin) by day 28 and continued to be greater (P < .05) throughout the 84 day postinjection period. The blood GSH-Px activity and the blood Se concentrations in the treatment group heifers did not reach concentrations considered indicative of Se adequacy (30 mU/min/mg hemoglobin and 0.10 μg/mL, respectively) except briefly, at 5 hours postinjection when the blood Se concentration of the treatment group was 0.131 ± 0.028 μg/mL. The mean serum GSH-Px activity of the treatment group did not differ at any time from that of the control group (P≥ .17). The mean (±SD) fractional excretion (FE) of Se, as an estimate of Se excretion, was greater (P < .05) in the treatment group heifers (n = 5; 6.2 ± 2.5%) than in the control heifers (n = 3; 1.3 ± 0.6%) at 24 hours postinjection. The mean (±SD) weight gain, from day 0 to day 84, for the treatment group heifers was 63.0 ± 18.1 kg and the mean weight gain for the control group heifers was 53.1 ± 7.3 kg at 84 days postinjection and there was no difference between the groups (P < .39). Conclusions drawn from this study include: 1) the increase in blood GSH-Px activity occurs approximately 28 days after Se injection given to Se-deficient heifers, 2) a single label dose of injectable Se does not result in blood Se concentrations or blood GSH-Px activity normally considered to be adequate, 3) the label dose of injectable Se, although therapeutically beneficial for nutritional myodegeneration (NMD), does not seem to be a desired method for long-term Se supplementation of cattle consuming a Se-deficient diet, and 4) blood Se is a better predictor of Se status than serum Se. (Journal of Veterinary Internal Medicine 1993; 7:342–348. Copyright © 1993 by the American College of Veterinary Internal Medicine.) 相似文献
15.
16.
17.
第一条为加强犬类管理,防止狂犬病的发生,保障公民健康和人身安全,维护社会公共秩序和城市市容环境卫生,根据有关法律、法规,结 相似文献
18.
19.
20.
S C Fitzpatrick 《Journal of animal science》1990,68(3):870-873
Concern over the presence of veterinary drug residues in food has been increasing world wide. Because of this concern the Food and Drug Administration's Center for Veterinary Medicine (CVM) has been involved on an international basis in efforts to develop food safety standards for veterinary drugs. The major thrust of the Codex Committee on Residues of Veterinary Drugs in Foods (CC/RVDF) has been to achieve international agreement on veterinary drugs issues. CVM is an active participant on this committee. The CC/RVDF has established a list of priority veterinary drugs that are, or that have the potential to cause trade problems as the result of public health concerns. Included in this list are anabolic hormones, chloramphenicol, sulfonamides, nitrofurans, nitroimidazoles, somatotropins, benzimidazoles and trypanocides. In the upcoming years, the CC/RVDF will work toward developing international maximum residue levels for these compounds. The evaluation of the toxicity of veterinary drug-bound residues is another area of international concern. In conjunction with the Bureau of Veterinary Medicine, Health and Welfare Canada, CVM is developing guidelines on biological models to demonstrate the safety of veterinary drug-bound residues. In working with veterinary drug regulators from other countries, CVM has new solutions to human food safety problems. 相似文献